Cohort study reveals low treatment failure rates under initial HAART in naive patients when drug toxicity is absent, suggesting drug tolerance drives early regimen changes.
If the current HAART regimen caused no toxicity, less than 10% of naïve patients discontinue their first HAART regimen because of failure after 1 year from starting therapy.
No takes yet. Share an insight, caveat, or question.
Monforte et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: